Related Experiment Video
Updated: Jul 5, 2025

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
15.7K
Evaluating dose coverage and conformity in stereotactic ablative body radiotherapy (SABR) plans
Serena O'Keeffe1, Cathy Fleming2, Luis León Vintró3
1Department of Physics, St. Luke's Radiation Oncology Network, St. Luke's Hospital, Dublin, Ireland; UCD School of Physics, University College Dublin, Ireland; St Luke's Institute of Cancer Research, Dublin, Ireland.
Summary
This study introduces an automated method to assess dose coverage and gradients in stereotactic ablative body radiotherapy (SABR), improving quality assurance for radiation therapy planning.
Area of Science:
- Medical Physics
- Radiation Oncology
- Radiotherapy Quality Assurance
Background:
- Current conformity metrics for stereotactic ablative body radiotherapy (SABR) have limitations.
- Accurate assessment of dose prescription and gradient near the planning target volume (PTV) edge is crucial for effective treatment.
- Automation of these checks can improve efficiency and consistency in radiotherapy planning.
Purpose of the Study:
- To develop an automated spatial assessment methodology for evaluating dose prescription and dose gradient from the PTV edge in SABR.
- To introduce a novel metric, the 'Internal PTV contour' distance, for assessing PTV size and shape relative to dose distribution.
- To establish baseline data and automation acceptability criteria using a cohort of SABR patients.
Main Methods:
- A Python-based script was developed to calculate linear distances from the PTV edge to specified isodose lines.
- Measurements were taken every 15 degrees on axial slices and along the central axis in the coronal plane.
- A new metric, 'Internal PTV contour' distance, was introduced and analyzed in 134 SABR patients.
Main Results:
- Median distances from the PTV edge to the 100% and 90% isodose lines were quantified in both axial and coronal planes.
- Dose gradient criteria were established for lung and non-lung SABR using a polynomial fit of median distance versus 'Internal PTV contour'.
- Acceptability criteria were defined as Median Distance + 1 mm for the 80% isodose and Median Distance + 2 mm for the 50% isodose.
Conclusions:
- The developed in-house script provides a high-quality, automated spatial assessment of PTV dose coverage and gradient.
- The novel 'Internal PTV contour' distance metric demonstrates a strong correlation with dose gradient.
- This methodology enhances the accuracy and automation of quality assurance in SABR planning.

